I read the PR too fast and missed these good parts:

Quote:

---

We are excited to begin U.S. trials over the next few months, working closely with our expert scientific team and founders.

---

and...

Quote:

---

Plus, we are now positioned to bring back the Oral-Lyn program with the clinical development of our reformulated Oral-Lyn II that is designed to require only two sprays for glycemic control. Generex will once again be a force in diabetes, and we are happy to have ALTuCELL as an integral part of our plans.”

---

So that is definitely a change from being constantly told by Joe that Oralyn is a blown asset and years away from anything happening.